Skip to main content
. Author manuscript; available in PMC: 2021 Mar 19.
Published in final edited form as: Vaccine. 2020 May 28;38(30):4679–4686. doi: 10.1016/j.vaccine.2020.05.029

Table 3.

Weighted prevalence of hepatitis B surface antigen (HBsAg) and seroprotection against measles, rubella, diphtheria, and tetanus among children 6–7 years old — Solomon Islands, 2016.

Hepatitis B n % (95% CI)

HBsAg positive 40 3.1 (2.0–4.9)
Seroprotection n % (95%CI)
Measles (≥53 MFI-bg) 1143 99 (98–99)
Rubella (≥10 IU/mL) 1144 99 (97–100)
Diphtheria Immunity Range
Seroprotected (≥0.01 IU/mL) 599 51 (47–55)
<0.01 IU/mL 557 49 (45–53)
0.01–0.09 IU/mL 475 40 (36–44)
≥0.1 IU/mL 124 11 (9–13)
Tetanus Immunity Range
Seroprotected (≥0.01 IU/mL) 987 85 (83–87)
<0.01 IU/mL 169 15 (13–17)
0.01–0.09 IU/mL 559 48 (43–53)
0.1–0.99 IU/mL 233 20 (18–22)
≥1 IU/mL 195 17 (12–23)

Wilson 95% confidence limits